Accumulating evidence has strongly linked TEAD1 disruption or MST kinases activation to many diseases, such as Sveinsson's chorioretinal atrophy, AC, AD, skeletal muscle atrophy, ALS and diabetes. The gene discussed is TEAD1; the disease is diabetes mellitus.